HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cesar A Moran Selected Research

Chromogranins

7/2011Spindle cell thymomas: an immunohistochemical study of 30 cases.
4/2010Primary sclerosing neuroendocrine carcinomas of the lung: A clinicopathologic and immunohistochemical study of 10 cases.
4/2007Diffuse pulmonary meningotheliomatosis.
9/2006Cystic well-differentiated neuroendocrine carcinoma (carcinoid tumor): a clinicopathologic and immunohistochemical study of two cases.
11/2005Primary parathyroid tumors of the mediastinum: a clinicopathologic and immunohistochemical study of 17 cases.
8/2003Neuroendocrine carcinomas (carcinoid tumor) of the testis. A clinicopathologic and immunohistochemical study of ten cases.
12/2002Small cell carcinoma of the cervix: a clinicopathologic and immunohistochemical study of 23 cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cesar A Moran Research Topics

Disease

67Neoplasms (Cancer)
06/2022 - 04/2002
10Thymoma (Thymic Carcinoma)
01/2022 - 07/2011
5Adenocarcinoma
10/2020 - 01/2010
4Adenocarcinoma of Lung
10/2020 - 11/2013
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 02/2005
4Carcinoma (Carcinomatosis)
01/2019 - 03/2009
4Lung Neoplasms (Lung Cancer)
01/2018 - 07/2010
3Small Cell Carcinoma
01/2021 - 12/2002
3Seminoma
03/2015 - 10/2014
3Neuroendocrine Carcinoma
12/2013 - 08/2012
3Neoplasm Metastasis (Metastasis)
07/2013 - 03/2007
2Carcinoid Tumor (Carcinoid)
06/2021 - 08/2012
2Necrosis
01/2021 - 08/2013
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
11/2019 - 11/2019
2Inflammation (Inflammations)
11/2019 - 11/2019
2Lymphoma (Lymphomas)
11/2019 - 11/2019
2Pleural Empyema (Pyothorax)
11/2019 - 11/2019
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2019 - 11/2019
2T-Cell Lymphoma (Lymphoma, T Cell)
11/2019 - 11/2019
2Primary Effusion Lymphoma
11/2019 - 11/2019
2Glandular and Epithelial Neoplasms (Neoplasms, Glandular)
01/2017 - 09/2011
2Hyperplasia
02/2015 - 04/2005
2Neuroendocrine Tumors (Neuroendocrine Tumor)
12/2014 - 07/2012
2Carcinogenesis
12/2013 - 09/2011
2Granuloma
08/2013 - 04/2005
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2012 - 07/2010
1Mesothelioma
12/2021
1Residual Neoplasm
01/2021
1Hodgkin Disease (Hodgkin's Disease)
11/2019
1Meningioma (Meningiomas)
12/2015
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
06/2015
1Liposarcoma
05/2015
1Melanoma (Melanoma, Malignant)
03/2015
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
03/2015
1Paraganglioma (Paragangliomas)
12/2014

Drug/Important Bio-Agent (IBA)

24Keratins (Keratin)IBA
01/2021 - 04/2002
10SynaptophysinIBA
03/2016 - 12/2002
9VimentinIBA
01/2021 - 04/2002
9Biological ProductsIBA
03/2016 - 04/2006
8Keratin-5 (Keratin 5)IBA
01/2019 - 07/2011
8AntibodiesIBA
01/2017 - 04/2002
7ChromograninsIBA
07/2011 - 12/2002
6CAM 5.2 antigenIBA
01/2019 - 06/2013
6Proteins (Proteins, Gene)FDA Link
05/2015 - 12/2002
5S100 Proteins (S 100 Protein)IBA
01/2021 - 04/2002
5Mucin-1 (CA 15-3 Antigen)IBA
08/2013 - 04/2002
4Thyroid Nuclear Factor 1IBA
01/2017 - 06/2012
4Calbindin 2IBA
01/2017 - 07/2011
3Coloring Agents (Dyes)IBA
01/2022 - 12/2018
3Carcinoembryonic AntigenIBA
12/2021 - 07/2004
3Biomarkers (Surrogate Marker)IBA
06/2021 - 01/2017
3Formaldehyde (Formol)FDA Link
10/2020 - 11/2013
3ParaffinIBA
10/2020 - 11/2013
3Transcription Factors (Transcription Factor)IBA
12/2014 - 09/2011
3DesminIBA
11/2011 - 04/2002
2Cathepsin KIBA
01/2021 - 01/2019
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
08/2020 - 02/2005
2FibrinIBA
11/2019 - 11/2019
2GlypicansIBA
01/2019 - 03/2015
2RNA (Ribonucleic Acid)IBA
01/2018 - 06/2017
2Keratin-7 (Cytokeratin 7)IBA
01/2018 - 01/2010
2LigandsIBA
01/2017 - 09/2012
2Chromogranin AIBA
03/2016 - 12/2014
2germ-cell AP isoenzymeIBA
10/2014 - 04/2005
2Inhibins (Inhibin)IBA
01/2014 - 06/2013
2CholesterolIBA
08/2013 - 04/2005
2ChromatinIBA
04/2011 - 01/2011
1EpitopesIBA
12/2021
1PaxillinIBA
06/2021
1Phosphotransferases (Kinase)IBA
10/2020
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
10/2020
1Progesterone Receptors (Progesterone Receptor)IBA
09/2020
1Estrogen ReceptorsIBA
09/2020
1Indicators and Reagents (Reagents)IBA
08/2020
1Immune Checkpoint InhibitorsIBA
03/2020
1xylometazoline (stas)IBA
08/2019
1Histones (Histone)IBA
01/2019
1Melanins (Melanin)IBA
12/2018
1Keratin-20 (Cytokeratin 20)IBA
01/2018
1DesmocollinsIBA
01/2017
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
07/2016
1MucinsIBA
06/2015
1Surface-Active Agents (Surfactants)IBA
06/2015
1Colloids (Colloid)IBA
06/2015
1Small Interfering RNA (siRNA)IBA
05/2015
1Carrier Proteins (Binding Protein)IBA
03/2015
1AntigensIBA
03/2015
1Transcription Factor 4IBA
03/2015
1Transcription Factor 3IBA
03/2015
1Neoplasm Antigens (Tumor Antigens)IBA
02/2015

Therapy/Procedure

11Therapeutics
01/2021 - 10/2011
5Drug Therapy (Chemotherapy)
01/2021 - 03/2007
5Neoadjuvant Therapy
01/2020 - 07/2011
3Radiotherapy
01/2021 - 02/2005
2Thoracotomy
06/2022 - 10/2014
2Breast Implants (Breast Implant)
11/2019 - 11/2019
2Thymectomy
03/2016 - 07/2012
2Adjuvant Chemotherapy
10/2011 - 07/2010
2Pneumonectomy (Lung Volume Reduction)
03/2009 - 11/2008
1Immunotherapy
01/2018